A Phase 1 First-in-Human Study of Tnb-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Background Prognosis is poor for patients (pts) with relapsed/refractory multiple myeloma (RRMM; median overall survival:

Bibliographic Details

Published in:	Blood 2021-11, Vol.138 (Supplement 1), p.900-900
Main Authors:	Kumar, Shaji, D'Souza, Anita, Shah, Nina, Rodriguez, Cesar, Voorhees, Peter M., Bueno, Orlando F., Buelow, Ben, Freise, Kevin J., Yue, Susan, Pothacamury, Rajvineeth Kumar, Polepally, Akshanth R., Vij, Ravi
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!